The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
531015-BOM Key Metrics
531015-BOM Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
531015-BOM Share Price
531015-BOM
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
531015-BOM Stock Analysis
Views
Red Flags
Positive
Strong revenue growth and above median growth of industry
Low Debt to Equity
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Low ROE
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Low operating margin but improving trend
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.00336845.
Snapshot
See detailed analysis
531015-BOM Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
531015-BOM Bulk, Block & Insider Trades
531015-BOM Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
Others
Write-off of capitalNominal value reduced from Rs 10 to Rs 5 followed by a Stock consolidation increasing the Nominal value from Rs 5 to Rs 10. Ex-date: 29th Jan 2009 Announced on: 23rd Jan 2009
Stock consolidationNominal value reduced from Rs 10 to Rs 5 followed by a Stock consolidation increasing the Nominal value from Rs 5 to Rs 10. Ex-date: 29th Jan 2009 Announced on: 23rd Jan 2009
Company Profile
Venmax Drugs and Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of pharmaceutical products, drug intermediaries and active pharmaceutical ingredients (API’s). It is developing oncology products through research and development (R&D).
Key personnel
Mr. Venkata Rao SadhanalaD
Additional Whole Time Director
Mr. Swapneswar MishraD
Additional Non-Executive Non-Independent Director
Mr. Dasi Reddy RakeshD
Additional Non-Executive Non-Independent Director
Mrs. Pilli Meena KumariD
Additional Non-Executive Independent Director
Mr. Gundluru ReddappaD
Additional Non-Executive Independent Director
Mr. Swapneswar MishraD
Additional Non-Executive Non-Independent Director
Shri. Raghavacharya VasudevanD
Additional Independent Director
Shri. Gajula GopalD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Venmax Drugs And Pharmaceuticals Ltd.?
The current share price of Venmax Drugs And Pharmaceuticals Ltd. is ₹ 26.44 as of 09 Jan 2026.
What is the PE ratio of Venmax Drugs And Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Venmax Drugs And Pharmaceuticals Ltd. is 52.72 as of the latest financial data.
What is the ROE and ROCE of Venmax Drugs And Pharmaceuticals Ltd.?
Venmax Drugs And Pharmaceuticals Ltd. has a Return on Equity (ROE) of -0.56% and a Return on Capital Employed (ROCE) of -51.23% as per the latest financial reports.
What is the market cap of Venmax Drugs And Pharmaceuticals Ltd.?
The market capitalization of Venmax Drugs And Pharmaceuticals Ltd. stands at ₹ 19.29 Cr.
What is the dividend yield of Venmax Drugs And Pharmaceuticals Ltd.?
The dividend yield of Venmax Drugs And Pharmaceuticals Ltd. is 0.00% based on the current market price.
What is the RSI of Venmax Drugs And Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Venmax Drugs And Pharmaceuticals Ltd. is 47.90.
What is the FII and DII holding in Venmax Drugs And Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Venmax Drugs And Pharmaceuticals Ltd. shares.
What sector does Venmax Drugs And Pharmaceuticals Ltd. belong to?
Venmax Drugs And Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Venmax Drugs And Pharmaceuticals Ltd. stock?
The beta of Venmax Drugs And Pharmaceuticals Ltd. stock is 0.37, indicating its volatility relative to the broader market.
